Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-24

Clinical Trial Update: Effect of Denosumab in Erosion Healing in RA [Phase 2]

View source ↗

Summary

Phase 2 trial investigating denosumab for erosion healing in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Denosumab (denosumab)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED